The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Camilla Hald Albertsen(Leo Pharma (Denmark)), Jens B. Simonsen(Professional Beef Services), Jayesh A. Kulkarni(FPInnovations), Dominik Witzigmann(FPInnovations), Karsten Petersson(Leo Pharma (Denmark)), Marianne Lind(Leo Pharma (Denmark))
Cited by 1,145
Related Papers
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
|International Journal of Pharmaceutics|2021|1.5k
The current landscape of nucleic acid therapeutics
|Nature Nanotechnology|2021|1.3k
On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA
|ACS Nano|2018|638
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
|Nucleic Acid Therapeutics|2018|562